期刊文献+

杨梅苷脂质体在动物体内药代吸收动力学初步研究 被引量:2

Preliminary study on the pharmacokinetics of myricitrin liposome in rats plasma
下载PDF
导出
摘要 目的:以游离杨梅苷作对比,考察降解速率和半衰期,首次初步研究杨梅苷脂质体在大鼠体内的药代吸收动力学。方法:两组大鼠分别肌肉注射游离杨梅苷溶液和杨梅苷脂质体,间隔相同时间,分别眼球取血,高效液相色谱法(HPLC)测定药物残留含量。依据药物残留浓度和时间的关系,采用统计矩模型,利用3P97程序计算药代动力学参数,求出杨梅苷脂质体的降解速率和半衰期。结论:杨梅苷脂质体在肌肉注射的大鼠血浆中可较稳定的存在,具有载体和缓释的作用。大鼠体内的药代动力学数据表明,与游离杨梅苷溶液相比,脂质体使杨梅苷血药浓度能够维持更长的时间,给药8h后,血中仍保持一定的浓度分布,消除半衰期t1/2,α由64.3min增至243.6min,药时曲线下面积(AUC)为游离杨梅苷溶液溶液的3.41倍。 Objective:to inspect the degradation rate and half-life of elimination and study the pharmacokinetics of myricitrin liposome in rats plasma,compared with dissociated myricitrin solution.Methods:the two groups of rats were injected dissociated myricitrin solution and myricitrin liposome respectively.The plasma,in which medicine residue levels was detected by HPLC,was geted from their eyeballs after the same time.According to the relationship between the concentration of drug residues in plasma and time,using Statistical Moment Model,the pharmacokinetics parameters of myricitrin liposome,degradation rate and half-life of elimination,was calculated by the 3P97 program.Results:The fixt myricitrin liposome had a stable quality in rats plasma as carrier and controlled release formulation.Empirical data indicated that,compared with dissociated myricitrin solution,the liposome made the blood concentration keep a longer time,after 8 hours of the infusion,a certain concentration distribution can also be detected,the half-life of elimination(t1/2,α)increased from 64.3min to 243.6min,and the AUC was 3.41 times over it.
出处 《中国食品添加剂》 CAS 北大核心 2010年第5期78-82,共5页 China Food Additives
基金 国家科技支撑计划(2006BAD27B04)资助
关键词 杨梅苷 脂质体 药物残留 消除半衰期 myricitrin liposome medicine residue levels half-life of elimination
  • 相关文献

参考文献2

二级参考文献14

  • 1宋卫中,刘蔚,马开.高效液相色谱法测定双黄连含片中黄芩苷和汉黄芩素的含量[J].时珍国医国药,2006,17(1):61-62. 被引量:1
  • 2周晓宁,杨滨.高效液相色谱-电化学检测法测定黄芩中3种有效成分的含量[J].中国中药杂志,2006,31(1):47-50. 被引量:19
  • 3Mora A, Paya M, Rios JL, et al. Structure-activity relationships of polymethoxyflavones and other flavonoids as inhibitors of nonenzymic lipid peroxidation [ J ]. Biochem Pharmacol, 1990,40 (4) :793 -797.
  • 4Ueng YF, Shyu CC, Lin YL, et al. Effects of baicalein and wogonin on drug-metabolizing enzymes in C57BL/6J mice [ J ]. Life Sci, 2000,67 ( 18 ) : 2189 - 2200.
  • 5Oka H, Yamamoto S, Kuroki T, et al. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to ( TJ- 9) [J]. Cancer, 1995,76(5) :743 -749.
  • 6Tsai TH, Chou C J, Tsai TR. Determination of wogonin in rat plasma by liquid chromatography and its pharmacokinetic application[ J ]. Planta Med,1996,62(3) :263 - 266.
  • 7Zuo F, Zhou ZM, Zhang Q, et al. Pharmacokinetic study on the multi-constituents of Hangqin-Tang Decoction in rats [ J ]. Biol Pharm Bull, 2003,26(7) :911 -919.
  • 8Wakabayashi I, Yasui K. Wogonin inhibits inducible prostaglandin E2 prodution in macrophages [ J ]. Eur J Pharmacol, 2000, 406(3) :477 -481.
  • 9Kimura Y, Okuda H, Arichi S. Effects of baicalein on leukotriene biosynthesis and degranulation in human polymorphonuclear leukocytes[ J ]. Biochim Biophys Acta,1987 ,922( 3 ) :278 - 286.
  • 10Kobuchi H, Droy-Lefaix MT, Christen Y, et al. Ginkgo biloba extract ( EGb761 ) : inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7 [ J ]. Biochem Pharmacol, 1997,53(6) :897 -903.

共引文献11

同被引文献15

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部